| GlaxoSmithKline AG - Relenza 5 mg, Disk (Pulverinhalation) |
| 55108 | | 01 | | Relenza 5 mg | | Disk (Pulverinhalation) | | J05AH01 | | Zanamivir | | 24.06.1999 | | |
|
| Composition |
| zanamivirum 5 mg pro dosi, lactosum monohydricum, ad pulverem. |
| Packungsbestandteile |
| Disk (Pulverinhalation) | | | | | | Principe actif | Concentr. |
|---|
| Zanamivir | 5 mg |
| | | | Agents auxilliaires |
|---|
| Lactose Monohydrate |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 20 unidose(s) | | | B | | Non |
|
